Genome-scale perturbation signatures from primary human CD4 <sup>+</sup> T cells improve genetics-based prioritization of immune drug targets
- DOI
- 10.64898/2026.09.12.748195
- Published
- 2026-09-16
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.09.12.748195,
title = {Genome-scale perturbation signatures from primary human CD4 <sup>+</sup> T cells improve genetics-based prioritization of immune drug targets},
author = {Han AL and Slotnik M and Fox DA and Dhindsa RS and Gudjonsson JE and Kahlenberg JM and Welch J.},
year = {2026},
doi = {10.64898/2026.09.12.748195},
url = {https://doi.org/10.64898/2026.09.12.748195}
}RIS
TY - JOUR TI - Genome-scale perturbation signatures from primary human CD4 <sup>+</sup> T cells improve genetics-based prioritization of immune drug targets AU - Han AL AU - Slotnik M AU - Fox DA AU - Dhindsa RS AU - Gudjonsson JE AU - Kahlenberg JM AU - Welch J. PY - 2026 DO - 10.64898/2026.09.12.748195 UR - https://doi.org/10.64898/2026.09.12.748195 ER -
APA
AL, H., M, S., DA, F., RS, D., JE, G., JM, K., & J., W. (2026). Genome-scale perturbation signatures from primary human CD4 <sup>+</sup> T cells improve genetics-based prioritization of immune drug targets. https://doi.org/10.64898/2026.09.12.748195
Source records
- europe-pmc · retrieved 2026-09-25T11:50:55.656Z